Research map: Life’s crucial 9, plasma proteomics, and the risk of major complications and mortality in MASLD

Back to the article

Papers in this map

  1. Gene Ontology: tool for the unification of biology · Michael Ashburner · 2000 · 45449 citations · Cited by this paper
  2. AQP7 deficiency drives adipose tissue remodeling and disrupts homeostasis · 2025 · Related
  3. Regularization Paths for Generalized Linear Models via Coordinate Descent · Jerome H. Friedman · 2010 · 21057 citations · Cited by this paper
  4. 1,1-Diethoxyethane increases insulin sensitivity and ameliorates obesity and dyslipidemia in mice fed high-fat diet · 2026 · Related
  5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2008 · 17695 citations · Cited by this paper
  6. Risk stratification at prediabetes onset and association with diabetes outcomes using EHR data · 2025 · Related
  7. mice: Multivariate Imputation by Chained Equations inR · Stef van Buuren · 2011 · 14248 citations · Cited by this paper
  8. GLP-1 receptor agonism results in reduction in hepatic ethanol metabolism · 2025 · Related
  9. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age · Cathie L. M. Sudlow · 2015 · 13948 citations · Cited by this paper
  10. Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) · 2026 · Related
  11. KEGG as a reference resource for gene and protein annotation · Minoru I. Kanehisa · 2015 · 8063 citations · Cited by this paper
  12. Adolescence as a key developmental window for nutrition promotion and cardiometabolic disease prevention · 2025 · Related
  13. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population · Giorgio Bedogni · 2006 · 3178 citations · Cited by this paper
  14. Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice · 2026 · Related
  15. Partial residuals for the proportional hazards regression model · David Schoenfeld · 1982 · 3035 citations · Cited by this paper
  16. An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice · 2026 · Related
  17. Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association · Donald M. Lloyd‐Jones · 2022 · 2785 citations · Cited by this paper
  18. Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups · 2025 · Related
  19. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  20. CD36: bridging metabolism, inflammation, and reproduction · 2026 · Related
  21. Plasma proteomic associations with genetics and health in the UK Biobank · Benjamin B. Sun · 2023 · 1726 citations · Cited by this paper
  22. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease · Laurent Castéra · 2019 · 1518 citations · Cited by this paper
  23. Recommendations for presenting analyses of effect modification and interaction · Mirjam J. Knol · 2012 · 1432 citations · Cited by this paper
  24. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  25. Metabolic functions of FABPs—mechanisms and therapeutic implications · Gökhan S. Hotamışlıgil · 2015 · 750 citations · Cited by this paper
  26. Changing epidemiology, global trends and implications for outcomes of NAFLD · Vincent Wai‐Sun Wong · 2023 · 750 citations · Cited by this paper
  27. Plasma protein patterns as comprehensive indicators of health · Stephen A. Williams · 2019 · 547 citations · Cited by this paper
  28. Positive Psychological Well-Being and Cardiovascular Disease · Laura Diane Kubzansky · 2018 · 438 citations · Cited by this paper
  29. CMAverse: A Suite of Functions for Reproducible Causal Mediation Analyses · Baoyi Shi · 2021 · 412 citations · Cited by this paper
  30. UK Biobank: bank on it · Lyle John Palmer · 2007 · 395 citations · Cited by this paper
  31. Atlas of the plasma proteome in health and disease in 53,026 adults · Yue‐Ting Deng · 2024 · 295 citations · Cited by this paper
  32. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary · Frank Tacke · 2024 · 206 citations · Cited by this paper
  33. Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI · Tao‐Tao Tang · 2021 · 129 citations · Cited by this paper
  34. Adherence to the EAT-Lancet diet, genetic susceptibility, and risk of type 2 diabetes in Swedish adults · Shunming Zhang · 2023 · 117 citations · Cited by this paper
  35. Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component · Allison E. Gaffey · 2024 · 104 citations · Cited by this paper
  36. Plasma lipidomics in early pregnancy and risk of gestational diabetes mellitus: a prospective nested case–control study in Chinese women · Yi Wang · 2021 · 102 citations · Cited by this paper
  37. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases · Mohammed Eslam · 2021 · 100 citations · Cited by this paper
  38. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD · Kathleen E. Corey · 2021 · 90 citations · Cited by this paper
  39. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis · Michael Huan Le · 2024 · 87 citations · Cited by this paper

Source: OpenAlex (CC0)